Cargando…

Resveratrol in Hepatitis C Patients Treated with Pegylated-Interferon-α-2b and Ribavirin Reduces Sleep Disturbance

Background: Hepatitis C virus infection and interferon treatment have shown to be risk factors for sleep disorder health-related quality of life. Aim: To determine whether the effects of resveratrol on sleep disorders were associated with different tests in subjects with chronic hepatitis C treated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pennisi, Manuela, Bertino, Gaetano, Gagliano, Caterina, Malaguarnera, Michele, Bella, Rita, Borzì, Antonio Maria, Madeddu, Roberto, Drago, Filippo, Malaguarnera, Giulia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5579690/ https://www.ncbi.nlm.nih.gov/pubmed/28820468 http://dx.doi.org/10.3390/nu9080897

Ejemplares similares

Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α 2b Plus Ribavirin: Effect on Work Performance; A Randomized Clinical Trial
por: Malaguarnera, Giulia, et al.
Publicado: (2014)

Resveratrol in Patients with Minimal Hepatic Encephalopathy
por: Malaguarnera, Giulia, et al.
Publicado: (2018)

Silybin supplementation during HCV therapy with pegylated interferon-α plus ribavirin reduces depression and anxiety and increases work ability
por: Malaguarnera, Giulia, et al.
Publicado: (2016)

Folate levels in hepatocellular carcinoma patients with portal vein thrombosis
por: Malaguarnera, Giulia, et al.
Publicado: (2020)

D-dimer plasmatic levels as a marker for diagnosis and prognosis of hepatocellular carcinoma patients with portal vein thrombosis
por: Malaguarnera, Michele, et al.
Publicado: (2018)

Serum Folate deficiency in HCV related Hepatocellular Carcinoma
por: Malaguarnera, Giulia, et al.
Publicado: (2022)

Anorectal mucosal melanoma
por: Malaguarnera, Giulia, et al.
Publicado: (2018)

Rosuvastatin reduces nonalcoholic fatty liver disease in patients with chronic hepatitis C treated with α-interferon and ribavirin: Rosuvastatin reduces NAFLD in HCV patients
por: Malaguarnera, Michele, et al.
Publicado: (2011)

Vitamin D Serum Levels in Patients with Statin-Induced Musculoskeletal Pain
por: Pennisi, Manuela, et al.
Publicado: (2019)

Potential role of probiotics on colorectal cancer prevention
por: Uccello, Mario, et al.
Publicado: (2012)

Elevated serum levels of Chromogranin A in hepatocellular carcinoma
por: Biondi, Antonio, et al.
Publicado: (2012)

Hepatocellular Carcinoma: Novel Molecular Targets in Carcinogenesis for Future Therapies
por: Bertino, Gaetano, et al.
Publicado: (2014)

The Immune System in Hepatocellular Carcinoma and Potential New Immunotherapeutic Strategies
por: Bertino, Gaetano, et al.
Publicado: (2015)

High Carbohydrate 19-9 Antigen Serum Levels in Patients with Nonmelanoma Skin Cancer and Primary Occult Cancer
por: Malaguarnera, Giulia, et al.
Publicado: (2020)

Centenarians and supercentenarians: a black swan. Emerging social, medical and surgical problems
por: Vacante, Marco, et al.
Publicado: (2012)

Lipoprotein(a) Serum Levels in Diabetic Patients with Retinopathy
por: Malaguarnera, Giulia, et al.
Publicado: (2013)

Thyroid disturbances in children treated with combined pegylated interferon-alpha and ribavirin for chronic hepatitis C
por: Rashed, Yasser K., et al.
Publicado: (2020)

Serum Markers of Intrahepatic Cholangiocarcinoma
por: Malaguarnera, Giulia, et al.
Publicado: (2013)

Carcinoembryonic Antigen Serum Levels in Nonmelanoma Skin Cancer
por: Latteri, Saverio, et al.
Publicado: (2018)

Lipoprotein(a) in Cardiovascular Diseases
por: Malaguarnera, Michele, et al.
Publicado: (2013)

Influence of Resveratrol on the Immune Response
por: Malaguarnera, Lucia
Publicado: (2019)

Decrease in Serum Vitamin D Level of Older Patients with Fatigue
por: Pennisi, Manuela, et al.
Publicado: (2019)

Carnitine Serum Levels in Frail Older Subjects
por: Malaguarnera, Giulia, et al.
Publicado: (2020)

Responsibility of hepatitis C virus in the development of hepatocellular carcinoma: From molecular alterations to possible solutions
por: Bertino, Gaetano, et al.
Publicado: (2018)

Neurotoxicity of Acrylamide in Exposed Workers
por: Pennisi, Manuela, et al.
Publicado: (2013)

Pegylated Interferon and Ribavirin Treatment for Hepatitis C Virus Infection
por: Kagawa, Tatehiro, et al.
Publicado: (2010)

Pegylated Interferon and Ribavirin in the Retreatment of Chronic Hepatitis C in Korea
por: Cho, Hyun Chin, et al.
Publicado: (2013)

Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirin
por: Carvalho-Filho, Roberto J, et al.
Publicado: (2010)

Organizing Pneumonia Associated with Pegylated Interferon α and Ribavirin Therapy
por: Chopra, Amit, et al.
Publicado: (2015)

Consensus Interferon Plus Ribavirin for Hepatitis C Genotype 3 Patients Previously Treated With Pegylated Interferon Plus Ribavirin
por: Abbas, Zaigham, et al.
Publicado: (2013)

Folate status in type 2 diabetic patients with and without retinopathy
por: Malaguarnera, Giulia, et al.
Publicado: (2015)

Comparison of Vitamin D and Resveratrol Performances in COVID-19
por: Russo, Cristina, et al.
Publicado: (2023)

Retreatment of Patients Nonresponsive to Pegylated Interferon and Ribavirin with Daily High-Dose Consensus Interferon
por: Meyer, Douglas F., et al.
Publicado: (2010)

Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?
por: Gonçales, Fernando L, et al.
Publicado: (2010)

Pegylated Interferon and Ribavirin Dosing Strategies to Enhance Sustained Virologic Response
por: Chak, Eric, et al.
Publicado: (2010)

Successful treatment of HCV/HBV/HDV-coinfection with pegylated interferon and ribavirin
por: Hartl, Janine, et al.
Publicado: (2012)

Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C
por: Aizawa, Nobuhiro, et al.
Publicado: (2013)

Effects of Host and virus related factors on Interferon-α+ribavirin and Pegylated-interferon+ribavirin treatment outcomes in Chronic Hepatitis C patients
por: Akram, Madiha, et al.
Publicado: (2011)

Carbohydrate 19.9 Antigen Serum Levels in Liver Disease
por: Bertino, Gaetano, et al.
Publicado: (2013)

Homocysteine Serum Levels in Diabetic Patients with Non Proliferative, Proliferative and without Retinopathy
por: Malaguarnera, Giulia, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8jtcantff7frmsbn8n4go5s6im